Addition of bevacizumab to standard radiation therapy and daily temozolomide is associated with minimal toxicity in newly diagnosed glioblastoma multiforme. (Q55463725)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Addition of bevacizumab to standard radiation therapy and daily temozolomide is associated with minimal toxicity in newly diagnosed glioblastoma multiforme. |
scientific article |
Statements
Addition of bevacizumab to standard radiation therapy and daily temozolomide is associated with minimal toxicity in newly diagnosed glioblastoma multiforme. (English)
1 reference
1 reference
Henry S Friedman
1 reference
Annick Desjardins
1 reference
Allan Friedman
1 reference
David A Reardon
1 reference
James J Vredenburgh
1 reference
Katherine B Peters
1 reference
James E Herndon
1 reference
Jennifer Marcello
1 reference
Leighann Bailey
1 reference
Stevie Threatt
1 reference
John Sampson
1 reference
30 October 2010
1 reference
82
1 reference
1
1 reference
58-66
1 reference